Company / Interest Expense
AVADEL PHARMACEUTICALS PLC Interest Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$10.8M
FY2024
5-year range
$9.9M / $13.0M
FY2020-FY2024
Trend
+9.5%
vs FY2023
Sector context
#27 of 44
Health Care
What the data says
At $11M, AVADEL PHARMACEUTICALS PLC's interest expense ranks #18 of 44 in the Health Care sector. Interest Expense has fluctuated over the past 10 years, ranging from $0 in FY2015 to $13M in FY2020.
Based on SEC 10-K filings.
$11M in FY2024 with a 5-year CAGR of -2.8%.
Improved from $12M to $11M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
#18 of 44 in Health CareTop 39% of 44This company $10.8M Sector average $291.0M
▼
-96.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.8%, indicating a declining trend.
- In FY2024, interest expense increased 9.5% year-over-year.
- Ranks #27 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.8M | +9.5% |
| FY2023 | $9.9M | -19.9% |
| FY2022 | $12.3M | +24.1% |
| FY2021 | $9.9M | -23.5% |
| FY2020 | $13.0M | +4.1% |
| FY2019 | $12.5M | +17.5% |
| FY2018 | $10.6M | +909.7% |
| FY2017 | $1.1M | +9.2% |
| FY2016 | $963.0K | - |
| FY2015 | $0 | -100.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026